Clinical features of hepatitis B virus-related hepatocellular carcinoma

被引：33
作者：
Ishikawa, Toru [1 ]
机构：
[1] Saiseikai Niigata Second Hosp, Dept Gastroenterol & Hepatol, Niigata 9501104, Japan
来源：
WORLD JOURNAL OF GASTROENTEROLOGY | 2010年 / 16卷 / 20期
关键词：
Hepatocellular carcinoma; Hepatitis B virus; LIVER RESECTION; INTERFERON; RECURRENCE; LAMIVUDINE; CIRRHOSIS; SURVIVAL; INFECTION; THERAPY; INTEGRATION; ABLATION;
D O I：
10.3748/wjg.v16.i20.2463
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Hepatocellular carcinoma (HCC) is a major cause of cancer death, and chronic hepatitis B is a serious worldwide problem. The epidemiology of HCC is distinctive. Hepatitis B virus (HBV) plays a major role in hepatocarcinogenesis. Prevention of HBV-related HCC is a key issue in current hepatology. This paper describes the prevention and clinical features of HBV-related HCC, along with a short review of the disease. (C) 2010 Baishideng. All rights reserved.
引用
收藏
页码：2463 / 2467
页数：5
相关论文
共 28 条
[1]  
Ikeda K, 1998, CANCER-AM CANCER SOC, V82, P827, DOI 10.1002/(SICI)1097-0142(19980301)82:5<827::AID-CNCR5>3.0.CO
[2]  
2-G
[3]   High viral loads, serum alanine aminotransferase and gender are predictive factors for the development of hepatocellular carcinoma from viral compensated liver cirrhosis [J].
Ishikawa, T ;
Ichida, T ;
Yamagiwa, S ;
Sugahara, S ;
Uehara, K ;
Okoshi, S ;
Asakura, H .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2001, 16 (11) :1274-1281
[4]   Secondary prevention of recurrence by interferon therapy after ablation therapy for hepatocellular carcinoma in chronic hepatitis C patients [J].
Ishikawa, Toru .
WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (40) :6140-6144
[5]   Improved survival for hepatocellular carcinoma with portal vein tumor thrombosis treated by intra-arterial chemotherapy combining etoposide, carboplatin, epirubicin and pharmacokinetic modulating chemotherapy by 5-FU and enteric-coated tegafur/uracil: A pilot study [J].
Ishikawa, Toru ;
Imai, Michitaka ;
Kamimura, Hiroteru ;
Tsuchiya, Atsunori ;
Togashi, Tadayuki ;
Watanabe, Kouji ;
Seki, Kei-ichi ;
Ohta, Hironobu ;
Yoshida, Toshiaki ;
Kamimura, Tomoteru .
WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (41) :5465-5470
[6]   The impact of hepatitis B viral load on recurrence after complete necrosis in patients with hepatocellular carcinoma who receive transarterial chemolipiodolization - Implications for viral suppression to reduce the risk oil cancer recurrence [J].
Jang, Jeong Won ;
Choi, Jong Young ;
Bae, Si Hyun ;
Yoon, Seung Kew ;
Woo, Hyun Young ;
Chang, U. Im ;
Kim, Chang Wook ;
Nam, Soon Woo ;
Cho, Se Hyun ;
Yang, Jin Mo ;
Lee, Chang Don .
CANCER, 2007, 110 (08) :1760-1767
[7]   Risk factors for recurring hepatocellular carcinoma differ according to infected hepatitis virus - An analysis of 236 consecutive patients with a single lesion [J].
Koike, Y ;
Shiratori, Y ;
Sato, S ;
Obi, S ;
Teratani, T ;
Imamura, M ;
Hamamura, K ;
Imai, Y ;
Yoshida, H ;
Shiina, S ;
Omata, M .
HEPATOLOGY, 2000, 32 (06) :1216-1223
[8]  
Kubo S, 2000, CANCER-AM CANCER SOC, V88, P1016, DOI 10.1002/(SICI)1097-0142(20000301)88:5<1016::AID-CNCR10>3.0.CO
[9]  
2-V
[10]   Effect of the presence of hepatitis B e antigen on prognosis after liver resection for hepatocellular carcinoma in patients with chronic hepatitis B [J].
Kubo, S ;
Hirohashi, K ;
Yamazaki, O ;
Matsuyama, M ;
Tanaka, H ;
Horii, K ;
Shuto, T ;
Yamamoto, T ;
Kawai, S ;
Wakasa, K ;
Nishiguchi, S ;
Kinoshita, H .
WORLD JOURNAL OF SURGERY, 2002, 26 (05) :555-560
123